Neuropeptides in neuroprotection and neuroregeneration (Record no. 11632)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04741nam a2200325Ia 4500 |
| 001 - CONTROL NUMBER | |
| control field | CRC0KE11386PDF |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | BD-DhSAU |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20151012144304.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m|||||o||d|||||||| |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr|||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 121017s2012 fluad sb 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781439830635 (ebook : PDF) |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | BD-DhSAU |
| Transcribing agency | BD-DhSAU |
| 090 ## - LOCALLY ASSIGNED LC-TYPE CALL NUMBER (OCLC); LOCAL CALL NUMBER (OCLC) | |
| Classification number (OCLC) (R) ; Classification number, CALL (RLIN) (NR) | QP552.N39 |
| Local cutter number (OCLC) ; Book number/undivided call number, CALL (RLIN) | N48 2012 |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) | |
| Classification number | 572.65 |
| Item number | N494 |
| 245 00 - TITLE STATEMENT | |
| Title | Neuropeptides in neuroprotection and neuroregeneration |
| Medium | [electronic resource] / |
| Statement of responsibility, etc. | edited by Fred J. Nyberg. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Boca Raton, Fla. : |
| Name of publisher, distributor, etc. | CRC Press, |
| Date of publication, distribution, etc. | 2012. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | xi, 304 p. : |
| Other physical details | ill. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | ch. 1. Neuropeptide systems : some basic concepts / Tomas H�okfelt ... [et al.] -- ch. 2. Neuropeptide biosynthesis / Margery C. Beinfeld -- ch. 3. Neuropeptide degradation related to the expression of the physiological action of neuropeptides / Chikai Sakurada ... [et al.] -- ch. 4. Neuropeptides, isolation, identification, and quantitation / Jolanta Kotlinska and Jerzy Silberring -- ch. 5. Cellular and molecular processes of neuronal damage and mechanisms in neuroprotection and neuroregeneration : focus on brain ischemia / Gregor Z�undorf, Daniel F�orster, and Georg Reiser -- ch. 6. Dynorphins in central nervous system pathology / Kurt F. Hauser ... [et al.] -- ch. 7. Postnatal stress procedures induce long-term endocrine and metabolic alterations involving different proopiomelanocortin- derived peptides / Alberto Loizzo ... [et al.] -- ch. 8. Prothymosin [alpha] : a novel endogenous neuroprotective polypeptide against ischemic damages / Hiroshi Ueda, Hayato Matsunaga, and Sebok K. Halder -- ch. 9. Influence of anabolic androgenic steroids on dynorphinergic pathways in rat's brain / Kristina Magnusson -- ch. 10. Angiotensin II receptors and neuroprotection / Robert E. Widdop ... [et al.] -- ch. 11. PACAP and cellular protection : cellular protection by members of the VIP/secretin family with an emphasis on pituitary adenylate cyclase-activating polypeptide (PACAP) / Lee E. Eiden -- ch. 12. General strategies of peptide synthesis / Aleksandra Misicka -- ch. 13. Addressing the interactions between opioid ligands and their receptors : classic and nonclassic cases / Luca Gentilucci -- ch. 14. Use of peptides as drug leads : a case study on the development of dipeptides corresponding to the heptapeptide substance P(1-7), with intriguing effects on neuropathic pain / Rebecca Fransson and Anja Sandstr�om -- ch. 15. Cognition-enhancing peptides and peptidomimetics / Fred J. Nyberg and Mathias Hallberg. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | "Preface Over the past four decades, the number of peptides identified as neurotransmitters or neuromodulators in the central and peripheral nervous systems has significantly increased. These compounds, known as neuropeptides, have been recognized for playing an important role in the communication between cells in a variety of neuronal networks. Although, a considerable number of neuropeptides have been characterized so far, their quantity is limited compared to the number of precursor proteins that are actually found to be expressed in cells of the nervous system. Numerous studies have confirmed that neuropeptides are involved in a number of biological activities. These include modulation of brain reward, pain processing, and immune response, as well as neuroendocrine regulations, control of neurovegetative functions, and trophic effects. In recent years, it has become evident that the role of neuropeptides as fast-acting neurotransmitters is challenged by the observation that many of them may act as growth factors by stimulating cell proliferation and slow-acting mitogenesis. It has thus been demonstrated that a number of neuroactive peptides, such as pituitary adenylate cyclase-activating polypeptide (PACAP), adrenocorticotrophin (ACTH), opioid peptides, somatostatin, and substance P, may modulate proliferation and cell viability. Some peptides act as stimulatory factors on brain circuits involved in cognition, whereas others may act as inhibitory factors. Accordingly, many neuropeptide systems appear as important targets for neuroprotective drugs and drugs that promote neuroregeneration"--Provided by publisher. |
| 530 ## - ADDITIONAL PHYSICAL FORM AVAILABLE NOTE | |
| Additional physical form available note | Also available in print edition. |
| 538 ## - SYSTEM DETAILS NOTE | |
| System details note | Mode of access: World Wide Web. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neuropeptides. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neuroprotective agents |
| General subdivision | Therapeutic use. |
| 655 #7 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| Source of term | lcsh |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nyberg, F. |
| 776 1# - ADDITIONAL PHYSICAL FORM ENTRY | |
| International Standard Book Number | 9781439830628 (hardback : alk. paper) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://marc.crcnetbase.com/isbn/9781439830635">http://marc.crcnetbase.com/isbn/9781439830635</a> |
| Electronic format type | application/PDF |
No items available.